IMO, just more fluff news in order to prop up the stock price. They are telegraphing their actions with the words they use in their PR's.
The excerpt you linked is a perfect example.
"RCHA reports, "In one of the studies with 52 patients, all but one of the patients treated with an infusion of our drug TPA increased the number of WBCs, some significantly. We know that WBCs are key to
fighting disease and are vital to many patients' treatment and recovery," said Rich Pharmaceuticals
CEO Ben Chang."
How many would you say are some? That is kind of vague, wouldn't you say?
Play the news beer. Wash, rinse, repeat.